Aimmune is a leader in developing treatments designed to reduce the frequency and severity of allergic reactions.

Recent News

Aimmune Announces First U.S. Patients Are Being Treated with Newly-Approved PALFORZIA™, the First Treatment for Peanut Allergy
Aimmune Announces New PALFORZIA™ Data Suggesting Increased Desensitization, Improved Tolerability and Continued Immunomodulation After 18 and 24 Months of Treatment
Aimmune Therapeutics Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Recent Operational Highlights
READ ALL NEWS

INVESTORS AND MEDIA

See the Future

We are targeting prevalent food allergies and you’re invited to experience it yourself.
SEE WHAT'S HAPPENING AT AIMMUNE

CAREERS

Join Our Team

We’re building a team that aims to transform how food allergies are treated. Learn more about our company and explore current openings.
CAREERS AT AIMMUNE